NCT04287296 is a NA clinical trial of Wakey! in Mental Wellbeing, sponsored by Method X Studios Ltd.

Who is sponsoring NCT04287296?

NCT04287296 is sponsored by Method X Studios Ltd.

What drugs are being tested in NCT04287296?

Interventions in NCT04287296: Wakey!.

What condition does NCT04287296 study?

NCT04287296 studies Mental Wellbeing.

Is NCT04287296 still recruiting?

NCT04287296 is currently completed. Last updated 23 February 2021.

Last reviewed 2021-02-23 · How we verify

NCT04287296

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A 12-week Feasibility Trial of a Mental Health Breakfast Show Wakey

Completed NA Last updated 23 February 2021

What this trial tests

NA trial testing Wakey! in Mental Wellbeing in 3,993 participants. Completed in 21 May 2020.

Timeline

20 January 2020

Primary endpoint
10 April 2020

21 May 2020

Quick facts

Lead sponsor	Method X Studios Ltd
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	3,993
Start date	20 January 2020
Primary completion	10 April 2020
Estimated completion	21 May 2020
Sites	1 location across United Kingdom

Drugs / interventions tested

Wakey!

Conditions studied

Mental Wellbeing — all drugs for Mental Wellbeing →

Sponsor

Method X Studios Ltd

Who can join

18 and older, any sex, with Mental Wellbeing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of Wakey! is to increase access to wellbeing support to lower socio-economic groups who have traditionally been excluded from the design and evaluation of digital mental health interventions. This feasibility study is designed to explore engagement, initial efficacy and experience of using Wakey! in the underserved populations in the United Kingdom. This will be used to further adapt and refine the intervention, so it is appealing and effective in the target populations.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Improving Access to Behavioral Strategies to Improve Mental Well-being With an Entertaining Breakfast Show App: Feasibility Evaluation Study.
Öeren M, Jordan I, Coughlin D, Turnbull S. · · 2022 · cited 1× · PMID 35319468 · DOI 10.2196/25715

Verify or expand the search:

Other recruiting trials for Mental Wellbeing

Currently open trials in the same condition.

NCT07102576 — MDMA-Assisted Therapy for Mental Healthcare Providers · Phase 1 · recruiting
NCT06287216 — Preliminary Evaluation of a Mental Health Program: a Comparison Study · NA · recruiting
NCT06423417 — RCT: the Effectiveness of LifeHack in Improving Mental Wellbeing in University Students. · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04287296 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Method X Studios Ltd
Last refreshed: 23 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04287296.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing